Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860092 · ClinicalTrials.gov registry record
New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System
A clinical trial, sponsored by Second Sight Medical Products.
- Terminated
- Registry status
- 53
- Enrollment target
NCT01860092 is a clinical trial that was terminated before completion, run by Second Sight Medical Products. The registered enrollment target is 53 participants.
The verdict
NCT01860092 was terminated before completion, sponsored by Second Sight Medical Products.
- TERMINATED
- Registry status
- 53 participants
- Enrollment target
Study Summary
This post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies. An attempt will be made to include all eligible and willing subjects implanted with Argus II System in the United States.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2014-01 |
| Est. Completion | 2020-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01860092
The ClinicalTrials.gov registry entry for NCT01860092 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Second Sight Medical Products, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01860092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01860092 about?
NCT01860092 is a clinical study titled "New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System". This post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies. An attempt will be made to include all eligible and willing subjects implanted with Argus II System in the United States.
What is the current status of trial NCT01860092?
This trial is currently terminated. The enrollment target is 53 participants. The study started on 2014-01. Estimated completion is 2020-03.
Who is sponsoring clinical trial NCT01860092?
This trial is sponsored by Second Sight Medical Products, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.